Loading...
Combined Atezolizumab and Chemotherapy for a Patient With Double Primary Cancers
Background: Immune checkpoint inhibitors are indicated for non-small cell lung cancer (NSCLC) and head and neck cancer, and combined treatment of immune checkpoint inhibitor and chemotherapy has recently been carried out in patients with NSCLC. However, there is no established standard therapy for s...
Na minha lista:
| Udgivet i: | In Vivo |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
International Institute of Anticancer Research
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984065/ https://ncbi.nlm.nih.gov/pubmed/31882503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11785 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|